Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28113032

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Apr 1
First author
Smith I

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 10;35(23):2718-2719. doi: 10.1200/JCO.2017.73.0424.
    note
    Source null
    related pmid
    28581884
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Aug 10;35(23):2719. doi: 10.1200/JCO.2017.73.2214.
    note
    Source null
    related pmid
    28581885
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2019 Feb 1;37(4):359. doi: 10.1200/JCO.18.02272.
    note
    Source null
    related pmid
    30695668
    relationship
    Erratum in

Authors and identifiers

  1. name
    Smith I
    type
    Author
  2. name
    Yardley D
    type
    Author
  3. name
    Burris H
    type
    Author
  4. name
    De Boer R
    type
    Author
  5. name
    Amadori D
    type
    Author
  6. name
    McIntyre K
    type
    Author
  7. name
    Ejlertsen B
    type
    Author
  8. name
    Gnant M
    type
    Author
  9. name
    Jonat W
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Dowsett M
    type
    Author
  12. name
    Hart L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Smith I
    type
    Author
  2. name
    Yardley D
    type
    Author
  3. name
    Burris H
    type
    Author
  4. name
    De Boer R
    type
    Author
  5. name
    Amadori D
    type
    Author
  6. name
    McIntyre K
    type
    Author
  7. name
    Ejlertsen B
    type
    Author
  8. name
    Gnant M
    type
    Author
  9. name
    Jonat W
    type
    Author
  10. name
    Pritchard KI
    type
    Author
  11. name
    Dowsett M
    type
    Author
  12. name
    Hart L
    type
    Author
bibliography ids
  1. nci-bib-4e2c73efedcc9a0304bd1b2b
book metadata
content sha256
45687f6742becbf78cab27145c6d24de422d6020a2c0af6522ea0ba8eac8004c
document type
citation
dois
  1. 10.1200/JCO.2016.69.2871
electronic publication date
display
2017 Jan 23
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28113032
immutable id
pubmed:28113032@45687f6742becbf78cab27145c6d24de422d6020a2c0af6522ea0ba8eac8004c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
10
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1041-1048
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 10;35(23):2718-2719. doi: 10.1200/JCO.2017.73.0424.
    note
    Source null
    related pmid
    28581884
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Aug 10;35(23):2719. doi: 10.1200/JCO.2017.73.2214.
    note
    Source null
    related pmid
    28581885
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2019 Feb 1;37(4):359. doi: 10.1200/JCO.18.02272.
    note
    Source null
    related pmid
    30695668
    relationship
    Erratum in
outcomes validated
false
pmid
28113032
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
d11db919175c281bfee5626c1975797feeffd4d8cb1331e85ce5bfaa089d4972
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Apr 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28113032/
title
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.

Preserved source evidence · Not medical advice